NurseJet
Back to Discover
Research ArticleResearch

Robotic-assisted knee replacement did not improve 12-month patient outcomes

Lancet (London, England) (PubMed)Sep 5, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A pragmatic randomized trial found no clinically meaningful 12-month patient benefit from robotic-arm-assisted versus conventional total knee replacement.

What NurseJet pulled from the source

The trial randomized 339 patients at 10 British hospitals. At 12 months, mean Forgotten Joint Scores were 49.2 with robotic assistance and 50.2 with conventional instruments; the adjusted difference was −1.5 points (95% CI −7.5 to 4.5).

Why this matters for nurses

Technology-assisted procedures should be evaluated by patient-centered recovery and safety outcomes, not technical novelty alone.

Bedside takeaway

Use the same ordered postoperative assessment, mobility, pain, and complication-prevention pathway regardless of the instrument system used.

Key takeaways

  • The between-group difference did not meet the prespecified 12-point target for clinical importance.
  • Robotic-assisted replacement was more costly as delivered in routine practice.
  • Sixteen participants in each group experienced one serious adverse event.

Practice implications

  • Use the same ordered postoperative assessment, mobility, pain, and complication-prevention pathway regardless of the instrument system used.

Limitations & cautions

  • Abstract-only summary. Findings apply to the Mako system as delivered in this trial; 36-month follow-up is ongoing.
  • AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Lancet (London, England) (PubMed)

Lancet (London, England) (PubMed). Robotic-arm-assisted versus conventional total knee replacement (RACER-Knee): a pragmatic, multicentre, participant-masked and assessor-masked, superiority, randomised controlled trial.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42624811/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Renal failure (PubMed)

A single-center retrospective cohort found that approximately one quarter of laboratory-defined acute kidney injury cases on internal medicine wards were not documented, particularly when maximal creatinine was lower.

Med-SurgAI summaryReview source

European heart journal (PubMed)

In the pragmatic TARGET-D randomized trial, vitamin D dosing titrated to a serum target did not significantly reduce the composite of death, recurrent myocardial infarction, heart-failure hospitalization, or stroke after myocardial infarction.

TelemetryMed-SurgAI summaryReview source

Journal of the American Medical Directors Association (PubMed)

A prospective Dutch nursing-home cohort found clinically important differences in illness burden across respiratory viruses, with influenza and human metapneumovirus standing out.

GeriatricsMed-SurgAI summaryReview source